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	 In	 this	 study,	 we	 report	 the	 synthesis	 of	 some	 new	 Schiff	 base	 compounds	 (1‐5)	 from	 the
reaction	of	amoxicillin	with	 some	aromatic	aldehydes	 in	 classical	 Schiff	 base	method.	These
derivatives	were	characterized	by	melting	point,	elemental	analysis,	FT‐IR	and	1H	NMR	data.
All	the	synthesized	compounds	were	evaluated	in	vitro	for	their	antibacterial	activities	against
two	 Gram	 positive	 (Staphylococcus	 aureus,	 Streptococcus	 faecalis)	 and	 two	 Gram	 negative
(Escherichia	coli,	Pseudomonas	aeruginosa)	microorganisms	in	different	concentrations	(10‐1,
10‐3,	10‐5	and	10‐7	M)	by	agar	diffusion	disk	method.	The	results	showed	 that	some	of	 these
derivatives	have	good	antibacterial	activities	compared	to	biological	activity	of	parent	drug.	
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1.	Introduction	
	
Amoxicillin	 (penicillin	 A),	 Figure	 1,	 a	 very	 popular,	 safe	
antibiotic	 and	 is	 usually	 the	 drug	 of	 choice	 within	 the	 class	
because	 it	 is	 better	 absorbed	 compared	 to	 other	 beta‐lactam	
antibiotics	 [1].	 It	 is	 a	 moderate‐spectrum,	 bacteriolytic,	 β‐
lactam	 antibiotic	 used	 to	 treat	 many	 different	 types	 of	
infections	 caused	 by	 susceptible	 microorganisms.	 it	 is	 active	
against	 a	wide	 range	of	Gram‐positive,	 and	 a	 limited	 range	of	
Gram‐negative	 organisms	 [2].	 It	 is	 also	 found	 that	 amoxicillin	
and	 its	 derivatives	 are	 very	 importance	 in	 many	 research	
studies,	such	as	pharmaceutical	and	biological	studies	[3‐6].					
Compounds	containing	an	azomethine	group	(imine)	are	a	
class	of	important	compounds	in	medicinal	and	pharmaceutical	
field.	 The	 biological	 applications	 of	 these	 compounds	 have	
attracted	 remarkable	 attention	 [7].	 Some	 Schiff‐bases	 were	
exhibits	 antibiotic,	 antiviral	 and	 antitumor	 agents	 because	 of	
their	specific	structure	[8].	The	wide	use	of	antibiotics	resulted	
in	 the	serious	medical	problem	of	drugs	resistance	and	public	
health	concern.	The	synthesis	of	new	derivatives	of	antibiotics	
has	 become	 an	 important	 task	 to	 cope	 with	 drug	 resistance	
problems	[9,10].		
Due	to	the	activities	associated	with	amoxicillin	and	imines,	
an	 attempt	was	made	 to	 generate	 new	 derivatives	 containing	
imine	 and	 amoxicillin	 in	 the	 same	 molecules	 (1‐5).	 All	 the	
synthesized	 compounds	 were	 further	 characterized	 and	
evaluated	for	antibacterial	activities.	
There	 are	 many	 interesting	 studies	 on	 the	 Schiff	 bases	
compounds	and	 their	complexes	derived	 from	antibiotics.	Naz	
and	 Iqbal	 [11]	 found	 that	 the	 Schiff	 base	 complexes	 derived	
from	 amoxicillin	 having	 good	 antibacterial	 activity	 in	 good	
range	when	comparison	to	control	 (Amoxicillin).	Also	 Joshi	et.	
al.	 [12]	 synthesized	 two	 ligands	 derived	 from	 amoxicillin	 and	
their	 complexes	 with	 many	 metals	 that	 it	 used	 in	 biological	
activates.	He	found	that	the	Schiff	base	ligands	were	found	to	be	
biologically	active	and	their	metal	complexes	display	enhanced	
antimicrobial	activity.	
	
	
	
Figure	1.	Amoxicillin	structure.	
	
2.	Experimental		
	
2.1.	Materials	and	physical	measurements	
	
All	reactants	and	solvents	used	in	this	study	were	reagents	
grade	 and	 they	 are	 available	 from	 Sigma‐Aldrich	 and	 Fluka	
companies.	 Amoxicillin	 trihydrate	 was	 supplied	 by	 Arab	
Company	for	Antibiotics	Industries	(ACAI)	in	Iraq.			
Melting	 points	 were	 determined	 on	 Electro‐thermal	
capillary	apparatus	and	are	uncorrected.	Elemental	analysis	(C,	
H,	N)	were	 carried	out	using	a	Euro‐Vector	model	EA	3000	A	
instrument.	The	FT‐IR	spectra	were	obtained	using	SHIMADZU	
model	FT‐IR‐8400S.	1H	NMR	spectra	were	obtained	on	BRUKER	
model	 Ultra	 shield	 300	 MHz	 spectrophotometer	 in	 DMSO‐d6	
solution	with	the	TMS	as	internal	standard.	
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Table	1.	Physical	properties,	elemental	analysis	and	FT‐IR	data	of	compounds	(1‐5).	
Compound	 M.p.,	°C	 Yield,	%	 FT‐IR,	cm‐1 Elemental	analysis,	calculated	(found),	%	
CH=N C H N	
1	 179‐182	 77	 1664 55.41	(55.23) 4.45	(4.21)	 11.24	(11.16)
2	 209‐211	(Dec.)	 62	 1662 61.65	(61.70) 5.39	(5.51)	 8.99	(9.04)
3	 218‐220	 67	 1664 59.61	(59.66) 5.21	(5.12)	 8.69	(8.61)
4	 215‐216	 71	 1663	 56.61	(56.50)	 4.54	(4.60)	 8.61	(8.55)	
5	 188‐190	 83	 1666	 51.89	(52.02)	 4.16	(4.27)	 7.89	(7.95)	
	
	
	
Scheme	1
	
	
2.1.1.	General	method	for	the	preparation	of	(5R,6R)‐6‐{[(E)‐
substitutedbenzilidene]amino}‐2‐(4‐hydroxyphenyl)	 acetyl]	
amino}‐3,3‐dimethyl‐7‐oxo‐4‐thia‐1‐azabicyclo[3.2.0]	
heptane‐2‐carboxylic	acid	(1‐5)	
	
The	 Schiff	 bases	 derived	 from	 substituted	 benzaldehydes	
and	 amoxicillin	 trihydrate	 were	 prepared	 using	 a	 modified	
method	similar	to	one	given	by	Joshi	et	al.	and	Al‐Garawi	et	al.	
[12,13].	A	solution	of	substituted	benzaldehydes	(1.1	mmol)	in	
ethanol	(10	mL)	and	amoxicillin	trihydrate	(0.419	g,	1.0	mmol)	
were	 mixed.	 The	 obtained	 solution	 was	 then	 magnetically	
stirred	 and	 refluxed	 for	 6	 h	 at	 boiling	 temperature.	 The	
obtained	brownish	red	solution	was	poured	in	cold	water	(100	
mL).	 The	 solid	 was	 filtered	 and	 washed	 several	 times	 with	
water	then	dried	in	air	for	2	h.		
	
2.1.2.	General	method	for	determination	the	antibacterial	
activity	of	Schiff	base	compounds	(1‐5)		
	
The	 prepared	 compounds	 (1‐5)	 were	 screened	 for	
antibacterial	activities	using	cup‐plate	agar	diffusion	method	by	
measuring	 the	 inhibition	 zone	 in	 mm	 [14,15].	 Amoxicillin	 in	
different	 concentrations	 (10‐1,	 10‐3,	10‐5	 and	10‐7	M)	was	used	
as	a	standard	drug	for	comparative	antibacterial	activity	of	the	
prepared	 compounds.	 The	 compounds	 were	 screened	 for	
antibacterial	activity	against	two	Gram	positive	(Staphylococcus	
aureus,	 Streptococcus	 faecalis)	 and	 two	 Gram	 negative	
(Escherichia	 coli,	 Pseudomonas	 aeruginosa)	 microorganisms	
that	 have	 been	 isolated	 from	 infected	 wounds,	 nose	 swab,	
urinary	tract	infection,	surgical	theaters,	respectively,	in	Muller	
Hinton	 agar.	 These	 sterilized	 agar	 media	 were	 poured	 into	
Petri‐dishes	and	allowed	to	solidify.	On	the	surface	of	the	media	
microbial	 suspensions	were	spread	with	 the	help	of	 sterilized	
triangular	 loop.	 A	 stainless	 steel	 cylinder	 of	 12	mm	 diameter	
(pre‐sterilized)	was	 used	 to	 bore	 cavities.	 All	 the	 synthesized	
compounds	in	different	concentrations	(10‐1,	10‐3,	10‐5	and	10‐7	
M)	were	placed	serially	in	cavities	with	the	help	of	micropipette	
and	allowed	to	diffuse	for	one	hr.	DMSO	was	used	as	a	solvent	
for	 all	 compounds	 and	 sterile	 distilled	 water	 was	 used	 as	 a	
solvent	for	pure	amoxicillin.	These	plates	were	incubated	at	37	
oC	 for	48	hr.	The	zone	of	 inhibition	observed	around	 the	cups	
after	respective	incubation	was	measured	in	mm.		
	
3.	Results	and	discussions		
	
3.1.	Synthesis	
	
Scheme	1	outline	the	synthetic	sequences	employed	in	our	
laboratories	 for	 preparation	 of	 Schiff	 base	 compounds	 (1‐5).	
The	 Schiff	 base	 derivatives	 of	 amoxicillin	 were	 prepared	 in	
good	yield	by	the	reaction	of	the	corresponding	benzaldehydes	
with	amoxicillin	trihydrate	in	absolute	ethanol	as	a	solvent.	The	
structural	 assignment	 of	 amoxicillin	 trihydrate	 was	 based	 on	
melting	point	(182‐184	oC	decomposed)	and	their	spectral	FT‐
IR	spectroscopy.	The	FT‐IR	spectrum	of	this	antibiotic	exhibited	
significant	 two	 bands	 at	 3332	 and	 3163	 cm‐1	which	 could	 be	
attributed	 to	 asymmetric	 and	symmetric	 stretching	vibrations	
of	NH2	group.	Besides	this,	bands	about	1776	and	1687	cm‐1	are	
due	 to	 	 C=O	 stretching	 for	 lactam	 and	 carboxyl	 groups	
respectively.	It	also	showed	a	broad	band	between	3041‐2621	
cm‐1	 due	 to	 stretching	 O‐H	 of	 carboxyl	 group	 (	 COOH).	 The	
bands	 that	appeared	at	3527	and	3462	 cm‐1	were	assigned	 to	
the	amide	(N‐H)	and	hydroxyl	group	(O‐H)	respectively.		
The	 FT‐IR	 spectra	 of	 compounds	 (1‐5)	 indicated	 the	
presence	 of	 	 CH=N	 function	 (1662‐1666	 cm‐1)	 and	disappear‐
ances	two	bands	at	(3332	cm‐1)	and	(3163	cm‐1)	which	could	be	
attributed	to	asymmetric	and	symmetric	stretching	vibration	of	
NH2	 group	 of	 amoxicillin.	 Reviews	 on	 1H	 NMR	 of	
Amoxicillin.3H2O	in	DMSO‐d6	solvent	 is	available	 in	references	
[16,17].	 The	 amine	 and	 carboxyl	 protons	 did	 not	 observed	 in	
the	spectrum	because	the	extent	of	intermolecular	interactions	
with	DMSO‐d6	[18,19].	The	1H	NMR	spectra	of	these	compounds	
1‐5	showed	a	singlet	at	δ	10.03,	9.98,	9.93,	9.87	and	10.29	ppm	
due	to	the	imines	protons,	respectively.	The	physical	properties	
and	FT‐IR	data	for	Schiff	bases	derivatives	are	listed	in	Table	1	
and	the	1H	NMR	data	are	listed	in	Table	2.					
	
3.2.	Antibacterial	studies		
	
All	 the	 synthesized	 compounds	 (1‐5)	 with	 parent	 drug	
(Amoxicillin	 tri	 hydrate)	 have	 been	 screened	 in	 vitro	 for	
antibacterial	activities.	
When	 we	 examine	 the	 data	 of	 (inhibition	 zone)	 of	 all	
compounds	(1‐5)	against	Staphylococcus	aureus	in	Figure	2,	we	
observe	some	important	results:	that	the	compounds	3,	4	and	5	
showed	biological	activities	more	than	the	parent	drug	and	that	
these	 activities	 increases	with	 increasing	 the	 concentration	of	
these	 compounds	 while	 compounds	 1	 and	 2	 showed	 the	
opposite.	Also,	the	compound	3	has	a	biological	activity	higher	
than	the	compounds	4	and	5.	
We	 note	 from	 Figure	 3,	 the	 activity	 against	 Streptococcus	
faecalis,		that	all	the	prepared	compounds,	except	compound	1,	
have	higher	biological	 activities	 than	 the	pure	amoxicillin	 and	
this	 efficiency	 increases	 with	 increasing	 the	 concentration	 of	
compounds,	 also	 the	 compound	 5	 has	 the	 highest	 activity	
against	this	type	of	bacteria	compared	to	others.		
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Table	2.	1H	NMR	data	of	compounds	(1‐5)	a.	
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Assignment		 Amoxicillin.3H2O	b	 Compound	1 Compound 2 Compound	3 Compound	4	 Compound	5
A‐CH3	 1.38	(s)	 1.31	(s)	 1.21	(s)	 1.32	(s)	 1.34	(s)	 1.39	(s)	
B‐CH3	 1.49	(s)	 1.56	(s) 1.48	(s) 1.50	(s) 1.48	(s)	 1.54	(s)
H‐3	 3.98	(s)	 3.99	(s)	 4.39	(s)	 3.86	(s)	 3.97	(s)	 3.99	(s)	
H‐10	 4.87	(s)	 4.76	(s) 4.82	(s) 4.79	(s) 4.81	(s)	 4.83	(s)
H‐5	 5.32	(d)	 5.29	(d) 5.39	(d) 5.44	(d) 5.33	(s)	 5.37	(s)
H‐6	 5.50	(s,	bd)	 5.68	(s,	bd) 5.51	(s,	bd) 5.66	(s,	bd) 5.69	(s,	bd)	 5.61	(s,	bd)
Ha	 6.77	(d)	 6.74	(d) 6.69	(d) 6.67	(d) 6.68	(d)	 6.70	(d)
Hb	 7.30	(d)	 7.33	(d) 7.21	(d) 7.25	(d) 7.23	(d)	 7.20	(d)	
NH	 8.68	(d)	 8.61	(d) 8.59	(d) 8.56	(d) 8.63	(d)	 8.61	(d)
OH	 9.05	(d)	 9.16	(d)	 9.11	(d)	 9.14	(d)	 9.09	(d)	 9.12	(d)	
NH2	 Not	observed	 ‐	 ‐ ‐ ‐ ‐	
CH=N	 ‐	 10.03	(s)	 10.01	(s)	 9.98	(s)	 10.02	(s)		 10.12	(s)	
COOH	 Not	observed	 11.07	(s)	 11.09	(s)	 11.10	(s)	 11.02	(s)	 11.04	(s)	
Hc	 ‐	 7.81	(d)	 7.79	(d)	 7.86	(s)	 7.61	(d)	 7.66	(d)	
Hd	 ‐	 8.32	(d) 8.37	(d) 8.40	(d) 8.18	(t)	 8.16	(t)
He	 ‐	 ‐	 ‐ ‐ 8.27	(t)	 8.22	(t)
Hf	 ‐	 8.32	(d) 8.37	(d) 8.40	(d) 8.36	(d)	 8.41	(d)
Hg	 ‐	 7.81	(d) 7.79	(d) 7.86	(d) ‐ ‐	
X	 ‐	 ‐	 2.26	(s) 4.04	(s) ‐ ‐	
Y	 ‐	 ‐	 ‐ ‐ ‐ ‐	
a	Abbreviations:	s=singlet;	d=doublet;	t=triplet;	bd=broad.	
b	The	data	was	taken	from	the	references	[16,17].		
	
	
 
	
Figure	2.	The	activity	of	compounds	(1‐5)	against	Staphylococcus	aureus	 in	
different	concentrations	(1	=	10‐1,	2	=	10‐3,	3	=	10‐5,	and	4	=	10‐7	M).	
	
	
 
	
Figure	3.	 The	 activity	 of	 compounds	 (1‐5)	 against	Enterococcus	 faecalis in	
different	concentrations	(1	=	10‐1,	2	=	10‐3,	3	=	10‐5,	and	4	=	10‐7	M).	
	
When	 comparing	 the	 biological	 activities	 of	 two	 types	 of	
Gram	 possitive	 (Staphylococcus	 aureus	 and	 Streptococcus	
faecalis)	for	all	compounds	we	find	that	compound	3	retains	its	
high	 effectiveness	 among	 all	 the	 derivatives	 and	 show	potent	
activity	against	Staphylococcus	aureus.		
On	 the	 other	 hand,	 when	 we	 show	 the	 results	 of	 activity	
against	Escherichia	coli,	Figure	4,	we	observed	some	important	
notes:	 the	 first	 that	 all	 compounds	 (1‐5)	 in	 all	 concentrations	
have	 good	 activity	 against	 this	 bacteria	 and	 this	 inhibition	
increases	with	increasing	the	concentration	of	compounds.	The	
second	 is	 the	 compound	 5	 has	 good	 activity	 compared	 to	
others.	
	
 
	
Figure	 4.	 The	 activity	 of	 compounds	 (1‐5)	 against	 Escherichia	 coli in	
different	concentrations	(1	=	10‐1,	2	=	10‐3,	3	=10‐5	and	4	=	10‐7	M).	
	
When	we	assess	the	results	of	the	biological	activity	of	the	
compounds	 (1‐5)	 against	 Pseudomonas	 aeruginosa,	 Figure	 5,	
we	 find	 that	 only	 two	 compounds	 (2	 and	3)	 have	 shown	 the	
activity	 higher	 than	 amoxicillin,	 while	 compounds	 4	 and	 5	
showed	 less	 activity	 than	 pure	 amoxicillin	 note	 that	with	 the	
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activity	 of	 compound	1	 towards	 these	bacteria	 almost	 similar	
to	the	activity	of	parent	drug.		
	
	
	
Figure	5.	The	activity	of	compounds	(1‐5)	against	Pseudomonas	aeruginosa
in	different	concentrations	(1	=	10‐1,	2	=	10‐3,	3	=	10‐5,	and	4	=	10‐7	M).	
 
4.	Conclusions	
	
Schiff	base	compounds	derived	from	amoxicillin	trihydrate	
were	 prepared	 and	 structurally	 characterized	 using	
spectroscopic	 techniques.	 The	 synthetic	 route	 started	 from	
reaction	 between	 amoxicyllin	 and	 appropriate	 substituted	
benzaldehydes	(4‐nitro	benzaldehyde,	4‐methyl	benzaldehyde,	
4‐methoxy	benzaldehyde,	2‐chloro	benzaldehyde	and	2‐bromo	
benzaldehyde)	 in	 ethanol.	 The	 Schiff	 base	 compounds	
containing	amoxicillin	moiety	have	been	evaluated	 in	vitro	 for	
their	 antimicrobial	 activities	 against	 two	 types	 of	 bacteria:	
Gram	 positive	 (Staphylococcus	 aureus,	 Streptococcus	 faecalis)	
and	Gram	negative	(Escherichia	coli,	Pseudomonas	aeruginosa)	
microorganisms	in	different	concentrations	(10‐1,	10‐3,	10‐5	and	
10‐7	M).	The	results	showed	that	some	of	these	derivatives	have	
good	antibacterial	activity	compared	to	the	parent	drug.			
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